SDGR Stock Analysis: Buy, Sell, or Hold?
SDGR - Schrodinger, Inc. Common Stock
$13.30
0.07 (0.53%)
▲
5d:
+11.3%
30d:
+16.56%
90d:
+18.54%
BUY
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When SDGR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SDGR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SDGR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SDGR is currently trading at $13.30, which is considered extended relative to its 30-day fair value range of $11.88 to $12.94.
Technical Outlook: Technically, SDGR is in a strong downtrend. The price is approaching resistance at $13.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SDGR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.88 (+57.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SDGR is in a strong downtrend. The price is approaching resistance at $13.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SDGR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.88 (+57.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.88 -
$12.94
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 57.0% below Wall St target ($20.88)
Trading Range Analysis
30-Day Trading Range
$11.88 -
$12.94
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.75
Resistance Level
$13.65
Current Trend
Strong Downtrend
Technical data as of
May 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.50
Wall Street Target
$20.88
(+57.0%)
Revenue Growth (YoY)
-1.6%
Profit Margin
-40.6%
Share & Embed Analysis
Last updated: May 26, 2026 5:45 AM ET
Data refreshes hourly during market hours. Next update: 6:45 AM
Data refreshes hourly during market hours. Next update: 6:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SDGR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Rachit Jain
SELL
844 shares
2026-04-16
Ramy Farid
SELL
43000 shares
2026-04-16
Jenny Herman
SELL
608 shares
2026-03-06
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$263 | 57 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 59 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$113 | 68 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$15 | 54 HOLD |
